Viewing Study NCT02285205


Ignite Creation Date: 2025-12-25 @ 3:16 AM
Ignite Modification Date: 2026-02-25 @ 2:43 AM
Study NCT ID: NCT02285205
Status: COMPLETED
Last Update Posted: 2016-02-02
First Post: 2014-11-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A 24 Week, Multicenter, Prospective, Open-labeled, Single-arm, Exploratory Phase 4 Clinical Trial to Evaluate the Safety and Efficacy of Lobeglitazone in Decreasing Intrahepatic Fat Contents in Type 2 Diabetes With NAFLD
Sponsor: Yonsei University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes View
None Non-alcoholic Fatty Liver Disease View
Keywords: